We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LZM icon
2001
Lifezone Metals
LZM
$285M
$19.7K ﹤0.01%
4,618
-915
-17% -$4.13K
LAZ icon
2002
Lazard
LAZ
$4.23B
$19.7K ﹤0.01%
406
+151
+59% +$7.54K
GFL icon
2003
GFL Environmental
GFL
$14.1B
$19.7K ﹤0.01%
458
-104
-19% -$4.65K
PI icon
2004
Impinj
PI
$3.95B
$19.7K ﹤0.01%
113
+36
+47% +$6.41K
INDB icon
2005
Independent Bank
INDB
$4.1B
$19.7K ﹤0.01%
269
HHH icon
2006
Howard Hughes
HHH
$3.93B
$19.6K ﹤0.01%
246
QS icon
2007
QuantumScape Corp
QS
$2.98B
$19.5K ﹤0.01%
1,876
SKYY icon
2008
First Trust Cloud Computing ETF
SKYY
$2.77B
$19.5K ﹤0.01%
150
RIVN icon
2009
Rivian
RIVN
$23.3B
$19.5K ﹤0.01%
988
-19
-2% -$302
FOLD
2010
DELISTED
Amicus Therapeutics
FOLD
$19.2K ﹤0.01%
1,350
DOLE icon
2011
Dole
DOLE
$1.38B
$19.2K ﹤0.01%
1,281
-2,157
-63% -$30K
RUSHB icon
2012
Rush Enterprises Class B
RUSHB
$6.01B
$19.2K ﹤0.01%
341
-6
-2% -$328
FNCL icon
2013
Fidelity MSCI Financials Index ETF
FNCL
$2.39B
$19.1K ﹤0.01%
246
KURA icon
2014
Kura Oncology
KURA
$834M
$19.1K ﹤0.01%
1,834
ZM icon
2015
Zoom
ZM
$26.8B
$19K ﹤0.01%
220
+65
+42% +$5.47K
RRR icon
2016
Red Rock Resorts
RRR
$3.85B
$19K ﹤0.01%
306
FV icon
2017
First Trust Dorsey Wright Focus 5 ETF
FV
$3.59B
$18.9K ﹤0.01%
300
JEMA icon
2018
JPMorgan ActiveBuilders Emerging Markets Equity ETF
JEMA
$1.56B
$18.9K ﹤0.01%
+385
New +$18.9K
TBLA icon
2019
Taboola.com
TBLA
$1.37B
$18.9K ﹤0.01%
4,089
-181
-4% -$681
MQ icon
2020
Marqeta
MQ
$1.9B
$18.8K ﹤0.01%
991
PCOR icon
2021
Procore
PCOR
$7.32B
$18.6K ﹤0.01%
256
BLMN icon
2022
Bloomin' Brands
BLMN
$746M
$18.6K ﹤0.01%
3,016
-530
-15% -$3.69K
INDI icon
2023
indie Semiconductor
INDI
$661M
$18.6K ﹤0.01%
5,267
+2,641
+101% +$11.6K
ENPH icon
2024
Enphase Energy
ENPH
$4.8B
$18.6K ﹤0.01%
579
-1,128
-66% -$36.5K
CECO icon
2025
Ceco Environmental
CECO
$3.91B
$18.6K ﹤0.01%
310

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.